PASG CIK: 1787297

Passage BIO, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−186
FY22:
−138
FY23:
−108
FY24:
−70.4
FY25:
−49.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−185
FY22:
−136
FY23:
−102
FY24:
−64.8
FY25:
−45.5

All amounts in millions USD Data source:SEC EDGAR